Evidence map›Paper›PMID 40175652›Full record

ArticleOncogene2025

Correction: CREB1-BCL2 drives mitochondrial resilience in RAS GAP-dependent breast cancer chemoresistance.

Ki-Fong Man, Omeed Darweesh, Jinghui Hong, Alexandra Thompson, Charlotte O'Connor, Chiara Bonaldo, Mark N Melkonyan, Mo Sun, Rajnikant Patel, Leif W Ellisen and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncogene, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Ki-Fong Man *University of Bristol, University Walk, Bristol, UK.
Omeed Darweesh *University of Bristol, University Walk, Bristol, UK.ORCID http://orcid.org/0000-0002-6369-296X
Jinghui Hong *University of Bristol, University Walk, Bristol, UK.
Alexandra ThompsonUniversity of Bristol, University Walk, Bristol, UK.
Charlotte O'ConnorUniversity of Bristol, University Walk, Bristol, UK.
Chiara BonaldoUniversity of Bristol, University Walk, Bristol, UK.
Mark N MelkonyanMassachusetts General Hospital, Boston, MA, USA.
Mo SunDepartment of Pathology, The First Hospital of Jilin University, Changchun, Jilin, China.
Rajnikant PatelUniversity of Leicester, Henry Wellcome Building, Lancaster, UK.
Leif W EllisenMassachusetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0003-0444-7910
Tim RobinsonUniversity of Bristol, University Walk, Bristol, UK.
Dong SongDepartment of Breast Surgery, General Surgery Centre, The First Hospital of Jilin University, Changchun, Jilin, China.
Siang-Boon KohUniversity of Bristol, University Walk, Bristol, UK. siangboon.koh@bristol.ac.uk.ORCID http://orcid.org/0000-0002-5494-3800

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40175652
PMCPMC11996673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.